With over a decade of experience, Anthony specializes in ensuring the highest standards of quality across the lifecycle of innovative therapies. Whether navigating complex raw material assessments, regulatory audits, or troubleshooting quality assurance challenges, he delivers strategic insights and solutions tailored to meet the unique needs of each client while empowering them to bring innovative therapies to market with confidence, ensuring the highest quality at every stage.

Anthony has worked extensively with cross-functional teams within Contract Development and Manufacturing Organizations (CDMOs) and pharmaceutical companies committed to advancing healthcare innovation. He has robust expertise in oncology-focused programs, cell and gene therapies, viral vectors, raw materials, and regulatory compliance, that provide him with a strong foundation to navigate the complexities of these cutting-edge fields and allows him to deliver solutions that meet both operational efficiency and regulatory standards, ensuring the safety, efficacy, and quality of each product. He is dedicated to translating complex scientific principles into practical, actionable strategies that help ensure product integrity throughout the production lifecycle.

Anthony has earned a BS in Biochemistry from the University of Texas-Permian Basin, a Graduate Certificate in Pharmaceutical Chemistry from the University of Florida, and an MS in Pharmaceutical Chemistry from the University of Florida.  

Grounded in a deep interdisciplinary collaboration, Daisy is devoted to bridging the worlds of direct patient care and research. Whether advising on protocol development, care transitions, patient-focused strategies or inclusive outreach, she integrates deep clinical insight with a human-centered approach that is rooted in empathetic and culturally sensitive care. She is focused on ensuring that innovations are scalable, evidence-based, scientifically sound, and deeply human.

Daisy has had the privilege of caring for patients across the lifespan—supporting and advocating for children and their families through complex medical journeys and life-altering diagnoses within fast-paced hospital environments and on research teams that bring hope and innovation to those affected by rare conditions. Her career has taken her from frontline pediatric, critical care, and oncology units to contributing to clinical trials supporting initiatives that are meticulously designed, executed, and compliant with regulatory standards. She offers strategic guidance, from protocol development to patient recruitment, that assists clients in bringing cutting-edge treatments to market with precision and care.

Daisy has earned a BA in Spanish Literature from the University of Texas-Permian Basin, a BS in Nursing from Texas Tech University Health Sciences Center-El Paso, and is currently working towards a PhD in Nursing from the University of Arizona.